Search results found: 5861
Publications
Date of Publication: Apr 2016
Mushaya, C., Chandra, R., Sansom, W., Keck, J. O.
Publications
Date of Publication: Apr 2016
Papakonstantinou, M. K., Hart, M. J., Farrugia, R., Gabbe, B. J., Moaveni, A. K., van Bavel, D., Page, R. S., Richardson, M. D.
Background The classification of proximal humeral fractures remains challenging. The two main classification systems used, the Neer and the AO classification, have both been shown to have less than ideal interobserver agreement. Agreement in classification is required, however, to guide fracture management.
Publications
Date of Publication: Jun 2016
Pattison, S., Mann, G. B., Crosthwaite, G., Lade, S., Mitchell, C., Leong, T., Busuttil, R. A., Boussioutas, A.
BackgroundGastric cancer (GC) is a common cause of cancer mortality. There are well-documented prognostic factors for GC but these have not been rigorously examined in an Australian context. This study examines the clinical, surgical and histopathological variables associated with survival in a GC cohort from a predominantly Caucasian-based population.
Publications
Date of Publication: Apr 2016
Shukla, L., Lim, E., Barker, A., Trotter, D. J.
Publications
Date of Publication: May 2016
St John, D. J. B.
Publications
Date of Publication: Jan-Feb 2016
Teloken, P. E., Ransom, D., Faragher, I., Jones, I., Gibbs, P., Platell, C.
BackgroundOutcomes of patients with stage I colorectal cancer submitted to surgery with curative intent have not been thoroughly explored in contemporary series. MethodsAll patients with colon or rectal adenocarcinoma who underwent resection from the St John of God Hospital (1996-2013) and BioGrid (1991-2013) databases were identified.
Publications
Date of Publication: Mar 2016
Tropea, J., Brand, C. A., Bohensky, M., Van Doornum, S.

Background: Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI fatality compared with the general population. In a previous study examining post-MI treatment in RA compared with controls we noted that a higher proportion of the RA patients had experienced MI following a surgical procedure.

Publications
Date of Publication: Jan 2016
Autry, T., Andersen, A.
Publications
Date of Publication: Mar 2016
Beith, J., Burslem, K., Bell, R., Woodward, N., McCarthy, N., De Boer, R., Loi, S., Redfern, A.
Endocrine therapy for the treatment of hormone receptor positive, HER2 negative, metastatic breast cancer is continually evolving. We systematically reviewed phase 2 and 3 randomized controlled trials (RCTs) of agents used in this setting to assess the effectiveness and safety of these agents for postmenopausal women.
Publications
Date of Publication: Mar 2016
Redfern, A., Burslem, K., Woodward, N., Beith, J., McCarthy, N., Boer, R., Bell, R.
Endocrine therapy is an established and effective treatment strategy for hormone receptor positive metastatic breast cancer. The clinical utility of endocrine therapy is lost over time due to evolving changes in tumor biology and the development of endocrine resistance. Many agents targeting the intracellular signaling pathways associated with endocrine resistance are in development.